Tiki, AmplifiDx & Hilltop Biosciences

At its meeting on June 8, 2021, Beacon Angels members entertained new funding proposals from the following presenters:

  • TIKI, building software to accord to social media users ownership over the data collected on them consisting of seeing it, controlling how it is used, when it is sold, and how to get paid for its sale; and
  • AmplifiDx, offering its Molecular Point-of-Care biotechnology platform in development of the DX 1000 System for infectious disease testing at the point of care; and
  • Hilltop BioSciences, a veterinary biotech offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis.

Members reported on Octagon Therapeutics in due diligence.

We heard updates on the funding rounds of:

  • AOA Dx,
  • GelMEDIX;
  • Cognoptix,
  • RevBio, and
  • Xeno Biosciences.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations. Bookmark the permalink.